AbCellera Biologics logo
AbCellera Biologics ABCL
$ 2.72 -5.88%

Quarterly report 2024-Q3
added 11-04-2024

report update icon

AbCellera Biologics Income Statement 2011-2024 | ABCL

Annual Income Statement AbCellera Biologics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

1.53 B 2.54 B 2.4 B 6 B - - - - - - - - -

Shares

289 M 285 M 276 M 159 M - - - - - - - - -

Historical Prices

5.28 8.91 8.71 37.7 - - - - - - - - -

Net Income

-146 M 159 M 153 M 119 M -2.21 M 309 K - - - - - - -

Revenue

38 M 485 M 375 M 233 M 11.6 M 8.83 M - - - - - - -

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - -

Operating Income

-237 M 217 M 204 M 156 M -4.12 M - - - - - - - -

Interest Expense

6.78 M -4.04 M -6.08 M -6.81 M -209 K - - - - - - - -

EBITDA

-213 M 244 M 219 M 158 M -738 K 1.76 M - - - - - - -

Operating Expenses

275 M 269 M 171 M 77.1 M 14 M 7.99 M - - - - - - -

General and Administrative Expenses

61 M 55.5 M 41.8 M 11.9 M 2.75 M 2.15 M - - - - - - -

All numbers in USD currency

Quarterly Income Statement AbCellera Biologics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

295 M 294 M 293 M 295 M 289 M 289 M 288 M 290 M 285 M 285 M 284 M 283 M 279 M 272 M 270 M 269 M 153 M 152 M 152 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-51.1 M -36.9 M -40.6 M - -28.6 M -30.5 M -40.1 M - 26.6 M -6.78 M 169 M - -21.4 M -2.32 M 117 M - -2.69 M 6.7 M -2.09 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

6.51 M 7.32 M 9.95 M - 6.6 M 10.1 M 12.2 M - 101 M 45.9 M 317 M - 5.51 M 27.6 M 203 M - 9.36 M 11.2 M 4.66 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-93.7 M -93.5 M -54.9 M - -54.9 M -51.4 M -64.9 M - 37.7 M -8.4 M 225 M - -28.1 M -7.03 M 158 M - -1.77 M -854 K -2.12 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

17.9 M 32.2 M -1.53 M - 2.05 M -1.97 M 3.59 M - 1.15 M -1.44 M 665 K - -1.26 M 314 K 265 K - -2.26 M -293 K -1 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

-89.9 M -90.1 M -50 M - -51.8 M -48.4 M -59.4 M - 42.9 M -3.51 M 229 M - -24.4 M -3.51 M 161 M - -1.73 M 39 K -1.55 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

100 M 101 M 64.8 M - 61.5 M 61.4 M 77.1 M - 63.6 M 54.3 M 91.6 M - 33.6 M 34.7 M 44.7 M - 11.1 M 12.1 M 6.78 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

19.1 M 20.2 M 17.4 M - 14.4 M 15.5 M 15.1 M - 13.8 M 14.4 M 14.3 M - 11.3 M 11.2 M 6.42 M - 2.97 M 1.5 M 1.65 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency